2026 Walter Berger: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	86	3024	2782	20	20	479	23203

Overview

Walter Berger is affiliated with the Medical University of Vienna in Austria. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focus on subfields such as Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Genetics, and Organic Chemistry.

The scientist's recent publications reflect a diverse interest in cancer research, metal complexes, and molecular mechanisms linked to oncology. Notable recent papers include:

Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma (2020, Cancer Cell)
Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD-100/KP1339 in the Endoplasmic Reticulum (2020, Angewandte Chemie International Edition)
Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands (2021, Journal of Medicinal Chemistry)
Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux (2020, Journal of Medicinal Chemistry)
A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance (2022, Communications Chemistry)

Walter Berger's work covers several main research topics including:

Glioma Diagnosis and Treatment
Metal complexes synthesis and properties
Occupational and environmental lung diseases
Cancer Research and Treatments
Cancer therapeutics and mechanisms
Neuroblastoma Research and Treatments
RNA modifications and cancer

The scientist has frequently published in venues such as:

Neuro-Oncology
Cancer Research
Inorganic Chemistry Frontiers
Cancers
Angewandte Chemie International Edition

Notable frequent coauthors in Walter Berger's collaborations include:

Christine Pirker
Johannes Gojo
Bernhard K. Keppler
Petra Heffeter
Dominik Kirchhofer

Best Publications

KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients.

Christian G. Hartinger;Christian G. Hartinger;Michael A. Jakupec;Stefanie Zorbas‐Seifried;Michael Groessl

1001
Citations
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

952
Citations
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

Robert Trondl;Petra Heffeter;Christian R. Kowol;Michael A. Jakupec

804
Citations
Anticancer activity of metal complexes: involvement of redox processes.

Ute Jungwirth;Christian R. Kowol;Bernhard K. Keppler;Christian G. Hartinger

579
Citations
Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development

Samuel M. Meier-Menches;Samuel M. Meier-Menches;Christopher Gerner;Walter Berger;Walter Berger;Christian G. Hartinger

419
Citations
Green tea extract and (–)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities

Leonilla Elbling;Rosa-Maria Weiss;Olga Teufelhofer;Maria Uhl

415
Citations
Metal Drugs and the Anticancer Immune Response.

Bernhard Englinger;Christine Pirker;Petra Heffeter;Alessio Terenzi;Alessio Terenzi

321
Citations
Resistance against novel anticancer metal compounds: differences and similarities

Petra Heffeter;Ute Jungwirth;Michael Jakupec;Christian Hartinger

298
Citations
Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity

W. Berger;E. Steiner;M. Grusch;L. Elbling

292
Citations
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

S. Kapitza;M. Pongratz;M. A. Jakupec;P. Heffeter

287
Citations
Spatio‐temporally precise activation of engineered receptor tyrosine kinases by light

Michael Grusch;Karin Schelch;Robert Riedler;Eva Reichhart

258
Citations
Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

Petra Heffeter;Katharina Böck;Bihter Atil;Mir Ali Reza Hoda

234
Citations
Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation

Christian R. Kowol;Robert Trondl;Petra Heffeter;Vladimir B. Arion

221
Citations
Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

Walter Berger;Ulrike Setinek;Peter Hollaus;Thomas Zidek

208
Citations
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.

Julia Riedl;Matthias Preusser;Pegah Mir Seyed Nazari;Florian Posch;Florian Posch

202
Citations
Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24).

Petra Heffeter;Michael A. Jakupec;Wilfried Körner;Stefan Wild

195
Citations
Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity.

M Bury;A Girault;Mégalizzi;S Spiegl-Kreinecker

193
Citations
Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents.

Laurent Ingrassia;Florence Lefranc;Janique Dewelle;Laurent Pottier

172
Citations
Uncertainty-aware exploration of continuous parameter spaces using multivariate prediction

W. Berger;H. Piringer;P. Filzmoser;E. Gröller

171
Citations
Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity

Wolfgang Kandioller;Evelyn Balsano;Samuel M Meier;Ute Jungwirth

157
Citations